Parental Germline Mosaicism: What It Means for aHUS Families
When a child is diagnosed with atypical haemolytic uraemic syndrome (aHUS), also known as complement-mediated thrombotic microangiopathy (cTMA), genetic testing often…
Triggering conditions
In this model of aHUS onset and relapse the two key variables are patient genetic predisposition and the "second hit"- ;.e.…
aHUS the micro-clot at ground zero
We all know that aHUS is the result of an overactive complement system naturally creating its weapon the membrane attack complex…
Genetic mutations strong or weak
In this model of the aHUS patient the concept of strong or weak aHUS disease causing genetic mutations is deployed not…
Precise and tailored- needed or not- surviving to thriving
It is fashionable these days to talk about precision medicine and tailor made/ personalised medicine. Whilst it is easy to say…
Every aHUS patient is in there somewhere.
aHUS alliance Global Action came up with this table describing aHUS patients position within a matrix of triggers and mutations guiding…
Thailand enters Global aHUS Town
A chance meeting at an American Kidney Fund conference a few days ago alerted us to aHUS patients in Thailand. So…
What aHUS patients think about a name change
If the name aHUS is to be changed and it remains a big IF as it remains in a state of…
aHUS Care in India: Moving to a’Hub and Spoke’ Model
Though atypical hemolytic uremic syndrome (aHUS) affects only 2 to 9 people per million globally, treatment strategies must include regional considerations…
- 1
- 2
- 3
- 4
- …
- 93
- Go to the next page